Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
Thrombosis and Haemostasis|June 1, 1997
Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisS Gandrille, D Borgel, H Ireland, et al.
Lancet (London, England)|October 5, 1996
Increased fetal loss in women with heritable thrombophiliaF E Preston, F R Rosendaal, I D Walker, et al.
Leukemia|May 15, 2009
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia veraD Olcaydu, R C Skoda, R Looser, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter studyB de Laat, V Pengo, I Pabinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 20, 2016
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia AR Klamroth, M Simpson, M von Depka-Prondzinski, et al.
Leukemia|December 3, 2016
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinibL Kazianka, C Drucker, C Skrabs, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levelsA D Shapiro, M V Ragni, R Kulkarni, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 16, 2002
Traveller's thrombosis 2001H Partsch, H Niessner, L Bergau, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2017
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case seriesA Iorio, A M Barbara, M Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|June 1, 1997
Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisS Gandrille, D Borgel, H Ireland, et al.
Lancet (London, England)|October 5, 1996
Increased fetal loss in women with heritable thrombophiliaF E Preston, F R Rosendaal, I D Walker, et al.
Leukemia|May 15, 2009
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia veraD Olcaydu, R C Skoda, R Looser, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter studyB de Laat, V Pengo, I Pabinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 20, 2016
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia AR Klamroth, M Simpson, M von Depka-Prondzinski, et al.
Leukemia|December 3, 2016
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinibL Kazianka, C Drucker, C Skrabs, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levelsA D Shapiro, M V Ragni, R Kulkarni, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 16, 2002
Traveller's thrombosis 2001H Partsch, H Niessner, L Bergau, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2017
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case seriesA Iorio, A M Barbara, M Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Pageof 22